SG Americas Securities, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$106,000
-27.4%
15,091
+0.7%
0.00%
-100.0%
Q1 2021$146,000
-54.2%
14,983
-52.6%
0.00%
-50.0%
Q3 2020$319,000
+63.6%
31,616
+37.0%
0.00%0.0%
Q1 2020$195,000
-82.4%
23,082
-77.6%
0.00%
-77.8%
Q3 2019$1,107,000
+427.1%
102,825
+1803.5%
0.01%
+350.0%
Q1 2019$210,000
+98.1%
5,402
+202.6%
0.00%
+100.0%
Q2 2018$106,000
-83.0%
1,785
-80.5%
0.00%
-80.0%
Q1 2018$624,000
+0.8%
9,165
+46.5%
0.01%
-16.7%
Q4 2017$619,000
+96.5%
6,258
+137.6%
0.01%
+100.0%
Q3 2017$315,000
+22.6%
2,634
-31.3%
0.00%0.0%
Q3 2016$257,000
+43.6%
3,834
+61.2%
0.00%
+200.0%
Q3 2015$179,000
-75.4%
2,378
-61.8%
0.00%
-80.0%
Q2 2015$728,000
+73.3%
6,233
+181.1%
0.01%
+150.0%
Q4 2014$420,000
+268.4%
2,217
+364.8%
0.00%
+100.0%
Q3 2014$114,000
-50.2%
477
-88.8%
0.00%0.0%
Q3 2013$229,0004,2700.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders